drugset / Trial / NCT04551586
A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants
RandomizedCrossoverOpen-labelBasic science
Summary
This will be an open-label, 3-sequence, 3-period crossover study in healthy adult participants to assess the relative bioavailability of ACH-0145228 when administered as an immediate release tablet versus powder-in-capsule.
Timeline
- Start
- 2020-06-26
- Primary completion
- 2020-10-19
- Completion
- 2020-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vemircopan | Small molecule | 240 mg | Oral |
Indications
No indication recorded.